Tao, Rachel E. http://orcid.org/0000-0002-4985-0546
Pixley, Jessica N. http://orcid.org/0000-0001-9049-1808
Holovach, Phillip G.
Fleischer, Alan B. Jr.
Feldman, Steven R. http://orcid.org/0000-0002-0090-6289
Article History
Received: 8 August 2023
Accepted: 26 September 2023
First Online: 13 October 2023
Declarations
:
: Steven R. Feldman has received research, speaking, and/or consulting support from AbbVie, Accordant, Almirall, Alvotech, Amgen, Arcutis, Arena, Argenx, Biocon, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly and Company, Eurofins, Forte, Galderma, Helsinn, Janssen, Leo Pharma, Micreos, Mylan, Novartis, Ono, Ortho Dermatology, Pfizer, Regeneron, Samsung, Sanofi, Sun Pharma, UCB, Verrica, Voluntis, and vTv Therapeutics. He is founder and part owner of Causa Research and holds stock in Sensal Health. Alan B. Fleischer Jr. is a consultant for Almirall, Incyte, Galderma, and SCM Lifescience (fees). He is an investigator for Cara, Galderma and Trevi (research support). Rachel E. Tao, Jessica N. Pixley, and Phillip G. Holovach have no conflicts to disclose.
: Only one Institutional Review Board (IRB) must review the NAMCS, and the NCHS Ethics Review Board (ERB) has done so.